Anti-CD3 zeta (phospho Y83) antibody [EP776(2)Y]
- 20ul selling size
- RabMAb
- Recombinant
- What is this?
Be the first to review this product! Submit a review
|
(21 Publications)
Rabbit Recombinant Monoclonal CD3 zeta phospho Y83 antibody. Suitable for IP, Flow Cyt (Intra), Dot, WB, ICC/IF and reacts with Human, Synthetic peptide samples. Cited in 21 publications.
View Alternative Names
CD247, CD3Z, T3Z, TCRZ, T-cell surface glycoprotein CD3 zeta chain, T-cell receptor T3 zeta chain
- Flow Cyt (Intra)
Lab
Flow Cytometry (Intracellular) - Anti-CD3 zeta (phospho Y83) antibody [EP776(2)Y] (AB68236)
Flow Cytometry analysis of Jurkat (human acute T cell leukemia) treated (Red)/untreated (Green) with 1mM pervanadate for 4 hours with purified ab68236 at 1/250 dilution. The secondary antibody was Goat anti rabbit IgG (Alexa Fluor® 488) at 1/2000 dilution. A Rabbit monoclonal IgG (Black) was used as the isotype control and cells without incubation with primary antibody and secondary antibody (Blue) were used as unlabeled control.
- ICC/IF
Supplier Data
Immunocytochemistry/ Immunofluorescence - Anti-CD3 zeta (phospho Y83) antibody [EP776(2)Y] (AB68236)
Immunocytochemistry/Immunofluorescence analysis of Jurkat cells (untreated, Per treated and Per+LP treated) labelling CD3 zeta (phospho Y83) with ab68236 (left) and CD3 zeta with ab40804 (right) both at a dilution of 1/200. Cells were fixed with 4% paraformaldehyde and permeabilized with 0.1% Triton X-100. ab150077, an Alexa Fluor® 488-conjugated goat anti-rabbit IgG (1/1000) was used as the secondary antibody. DAPI (blue) was used as the nuclear counterstain. ab7291, a mouse anti-tubulin (1/1000) and ab150120, an Alexa Fluor® 594-conjugated goat anti-mouse IgG (1/1000) were also used.
The image shows increased cytoplamic staining after Pervanadate (1 mM, 30 min) treatment on Jurkat cells. The LP treatment decreased the cytoplasmic staining caused by Pervanadate.
ab40804 was used as a Pan control for ab68236. The results showed cytoplamic staining on untreated, pervanadate (1 mM, 30 min) treated and Per+LP treated Jurkat cells.
- IP
Lab
Immunoprecipitation - Anti-CD3 zeta (phospho Y83) antibody [EP776(2)Y] (AB68236)
CD3 zeta was immunoprecipitated from 0.35 mg Jurkat (Human T cell leukemia T lymphocyte) treated with pervandate (50mM 5min) whole cell lysate 10 μg with ab68236 at 1/30 dilution (2μg) . VeriBlot for IP Detection Reagent (HRP)(ab131366) was used at 1/5000 dilution.
Lane 1 : Jurkat (Human T cell leukemia T lymphocyte) treated with pervandate (50mM 5min) whole cell lysate 10 μg
Lane 2 : ab68236 IP in Jurkat treated with pervandate (50mM 5min) whole cell lysate
Lane 3 : Rabbit monoclonal IgG (ab172730) instead of ab68236 in Jurkat treated with pervandate (50mM 5min) whole cell lysate
Blocking and dilution buffer and concentration : 5% NFDM/TBST.
All lanes:
Immunoprecipitation - Anti-CD3 zeta (phospho Y83) antibody [EP776(2)Y] (ab68236)
Predicted band size: 19 kDa
Observed band size: 18-22 kDa
false
- WB
Lab
Western blot - Anti-CD3 zeta (phospho Y83) antibody [EP776(2)Y] (AB68236)
Blocking buffer 5% NFDM/TBST
Diluting buffer 5% NFDM/TBST
All lanes:
Western blot - Anti-CD3 zeta (phospho Y83) antibody [EP776(2)Y] (ab68236) at 1/2000 dilution
Lane 1:
Untreated Jurkat cells whole cell lysates at 10 µg
Lane 2:
Jurkat cells were treated with 50mM Pervanadate for 5 minutes whole cell lysates at 10 µg
Lane 3:
Jurkat cells were treated with 50mM Pervanadate for 5 minutes whole cell lysates, then the membrane was incubated with Alkaline phosphatase at 10 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Predicted band size: 19 kDa
Observed band size: 18 kDa
false
Exposure time: 3min
- WB
Unknown
Western blot - Anti-CD3 zeta (phospho Y83) antibody [EP776(2)Y] (AB68236)
All lanes:
Western blot - Anti-CD3 zeta (phospho Y83) antibody [EP776(2)Y] (ab68236) at 1/10000 dilution
Lane 1:
Jurkat cell lysate, untreated. at 10 µg
Lane 2:
Jurkat cell lysate, treated with pervanadate at 10 µg
Secondary
All lanes:
HRP-conjugated goat anti-rabbit IgG at 1/2000 dilution
Predicted band size: 19 kDa
Observed band size: 18-22 kDa
false
- Dot
Unknown
Dot Blot - Anti-CD3 zeta (phospho Y83) antibody [EP776(2)Y] (AB68236)
Dot blot analysis of CD3 zeta (pY83) phospho peptide (lane 1) and CD3 zeta non-phospho peptide (lane 2) labelling CD3 zeta (phospho Y83) with ab68236 at a dilution of 1/1000. A peroxidase-conjugated goat anti-rabbit IgG (H+L) was used as the secondary antibody (1/2500).
Blocking and dilution buffer : 5% NFDM/TBST.
Exposure time : 3 minutes.
Related conjugates and formulations (7)
-
519 FITC
FITC Anti-CD3 zeta (phospho Y83) antibody [EP776(2)Y]
-
665 Alexa Fluor® 647
Alexa Fluor® 647 Anti-CD3 zeta (phospho Y83) antibody [EP776(2)Y]
-
Anti-CD3 zeta (phospho Y83) antibody [EP776(2)Y] - BSA and Azide free
-
617 Alexa Fluor® 594
Alexa Fluor® 594 Anti-CD3 zeta (phospho Y83) antibody [EP776(2)Y]
-
519 Alexa Fluor® 488
Alexa Fluor® 488 Anti-CD3 zeta (phospho Y83) antibody [EP776(2)Y]
-
565 Alexa Fluor® 555
Alexa Fluor® 555 Anti-CD3 zeta (phospho Y83) antibody [EP776(2)Y]
-
603 Alexa Fluor® 568
Alexa Fluor® 568 Anti-CD3 zeta (phospho Y83) antibody [EP776(2)Y]
Reactivity data
Product details
Species reactivity
Mouse, Rat: We have preliminary internal testing data to indicate this antibody may not react with these species.
Please contact us for more information.
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (21)
Recent publications for all applications. Explore the full list and refine your search
Frontiers in immunology 16:1571590 PubMed40642095
2025
Applications
Unspecified application
Species
Unspecified reactive species
iScience 28:112266 PubMed40241752
2025
Applications
Unspecified application
Species
Unspecified reactive species
Cell reports 43:114761 PubMed39276348
2024
Applications
Unspecified application
Species
Unspecified reactive species
Molecular cancer 22:200 PubMed38066564
2023
Applications
Unspecified application
Species
Unspecified reactive species
eLife 12: PubMed37796108
2023
Applications
Unspecified application
Species
Unspecified reactive species
Communications biology 6:911 PubMed37670137
2023
Applications
Unspecified application
Species
Unspecified reactive species
International journal of molecular sciences 22: PubMed33572206
2021
Applications
Unspecified application
Species
Unspecified reactive species
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 34:8959-8974 PubMed32469452
2020
Applications
Unspecified application
Species
Unspecified reactive species
Cancer cell 37:216-225.e6 PubMed32004441
2020
Applications
Unspecified application
Species
Unspecified reactive species
Cell reports 29:3506-3521.e6 PubMed31825832
2019
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com